Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Alert

Our attorneys stay on top of changes in legislation, agency regulations, case law, and industry trends—then craft timely legal alerts to keep clients up to date on legal developments important to their business.

July 7, 2021

New York State Department of Labor Issues HERO Act Guidance

As discussed in our prior legal alert, on May 5, 2021, NYS Governor Cuomo signed the Health and Essential Rights (HERO) Act into law. Governor Cuomo subsequently signed a bill amending certain provisions of the HERO Act. 

As previously noted, in the wake of the COVID-19 pandemic, the HERO Act directed the New York State Department of Labor (NYSDOL), in consultation with the New York State Department of Health (NYSDOH), to develop a model airborne infectious disease standard. The NYSDOL has now published its model standard, which can be accessed here.

Additionally, the NYSDOL has published a model airborne infectious disease exposure prevention plan, which can be accessed here, as well as industry-specific model exposure prevention plans for the agriculture, construction, delivery services, domestic workers, emergency response, food services, manufacturing and industry, personal services, private education, private transportation, and retail industries. The HERO Act requires employers in New York State to adopt one of the model plans or to create their own plan that equals or exceeds the minimum standards published by the NYSDOL by August 5, 2021. Employers are also required to post, distribute, and review the plan with employees.

Separately, employers with 10 or more employees are required to permit establishment of joint labor-management safety committees composed of two-thirds nonsupervisory employees. These safety committees have the authority to engage in the following activities:

  • Raise health and safety concerns
  • Review policies relating to occupational safety and health
  • Review policies adopted in response to health and safety laws, rules, and regulations
  • Participate in site visits by a governmental agency responsible for enforcing health and safety standards
  • Review reports filed by the employer related to health and safety of the workplace
  • Regularly schedule meetings once per quarter for up to two hours 

In addition, employers are required to allow safety committee designees to attend up to four hours of training without loss of pay. The safety committee provisions of the HERO Act do not become effective until November 2021; however, employers should begin planning now for how they will address these new requirements.

If you have any questions regarding the content of this alert, please contact Bob Heary, Labor & Employment Practice Area Chair, at rheary@barclaydamon.com, or another member of the firm’s Labor & Employment Practice Area.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

EPA Lists Two New "Forever Chemicals" Under CERCLA

Alerts

NYS Governor Hochul Announces Final RFP for New Certified Community Behavioral Health Clinics

Alerts

The Second Department Affirms Successful Storm in Progress Defense of Slip and Fall Case

Alerts

The New York FY 2025 Budget – CDPAP FIs Under Threat

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Anderson, Beauchamp, Murray, Angeles, Monegro, and Bullock—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Updated Bulletin on Tracking Technologies in the Health Care Industry

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out